pI: 7.6973 |
Length (AA): 322 |
MW (Da): 36499 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128432)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G12350 | phosphopantothenate--cysteine ligase 1 |
Arabidopsis thaliana | AT5G02080 | DNA / pantothenate metabolism flavoprotein |
Babesia bovis | BBOV_III006270 | DNA / pantothenate metabolism flavoprotein |
Brugia malayi | Bm1_45070 | DNA / pantothenate metabolism flavoprotein |
Candida albicans | CaO19.7357 | similar to S. cerevisiae YIL083C |
Cryptosporidium hominis | Chro.40256 | ENSANGP00000013327 |
Cryptosporidium parvum | cgd4_2250 | putative phosphopantothenoylcysteine synthetase |
Dictyostelium discoideum | DDB_G0282611 | phosphopantothenatecysteine ligase |
Drosophila melanogaster | Dmel_CG5629 | Phosphopantothenoylcysteine synthetase |
Echinococcus granulosus | EgrG_000906400 | yil083c protein |
Echinococcus multilocularis | EmuJ_000906400 | yil083c protein |
Homo sapiens | 79717 | phosphopantothenoylcysteine synthetase |
Leishmania braziliensis | LbrM.25.1460 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_251980.1 | phosphopantothenate--cysteine ligase, putative |
Leishmania infantum | LinJ.25.1980 | hypothetical protein, conserved |
Leishmania major | LmjF.25.1900 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.25.1900 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_01280 | DNA/pantothenate metabolism flavoprotein |
Mus musculus | ENSMUSG00000028636 | phosphopantothenoylcysteine synthetase |
Oryza sativa | 4344795 | Os08g0176100 |
Oryza sativa | 4329749 | Os02g0575200 |
Plasmodium berghei | PBANKA_0613600 | phosphopantothenate--cysteine ligase, putative |
Plasmodium falciparum | PF3D7_0412300 | phosphopantothenoylcysteine synthetase, putative |
Plasmodium falciparum | PF3D7_1102400 | phosphopantothenate--cysteine ligase, putative |
Plasmodium knowlesi | PKNH_0310500 | phosphopantothenate--cysteine ligase, putative |
Plasmodium vivax | PVX_000630 | phosphopantothenoylcysteine synthetase, putative |
Plasmodium yoelii | PY05326 | hypothetical protein |
Saccharomyces cerevisiae | YIL083C | phosphopantothenate--cysteine ligase CAB2 |
Schistosoma japonicum | Sjp_0215850 | ko:K01922 phosphopantothenate-cysteine ligase [EC6.3.2.5], putative |
Schistosoma japonicum | Sjp_0312350 | IPR007085,DNA/pantothenate metabolism flavoprotein, C-terminal,domain-containing |
Schistosoma japonicum | Sjp_0115150 | IPR007085,DNA/pantothenate metabolism flavoprotein, C-terminal,domain-containing |
Schistosoma mansoni | Smp_131090 | cornichon |
Schmidtea mediterranea | mk4.000616.08 | PhosphopantothenateALQ-cysteine ligase |
Trypanosoma brucei gambiense | Tbg972.3.1890 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.3.1970 | phosphopantothenoylcysteine synthetase, putative |
Trypanosoma congolense | TcIL3000_3_1070 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.504045.80 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_318600 | DNA /pantothenate metabolism flavoprotein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.1970 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.1970 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.1970 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.1970 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YIL083C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0613600 | Plasmodium berghei | Dispensable | plasmo |
TGME49_318600 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Tbru014591; Recombinant protein: full-length; Source: T brucei; hypothetical protein, conserved ; |
1 literature reference was collected for this gene.